Sperm DNA Peer-review Journals
Sperm DNA is vulnerable to oxidative damage due to inherent and extrinsic factors which cause
oxidative stress and due to partial DNA damage detection and repair mechanism. Reactive oxygen
species (ROS) are the chief cause of sperm DNA damage. So, this study was strategic to assess
oxidative stress levels and correlate with sperm DNA damage. Men in the reproductive age group may knowledge qualitative and quantitative defect in sperm production, but there are men with usual sperm parameters who are infertile, such cases are classified with idiopathic infertility. Scholarly peer review is the process of subjecting an author's scholarly work, research, or ideas to the scrutiny of others who are experts in the same field, before a paper describing this work is published in a journal. The work may be accepted, considered acceptable with revisions, or rejected. Peer review requires a community of experts in a given (narrowly defined) field, who are qualified and able to perform reasonably impartial review.
High Impact List of Articles
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
The handling of missing data in clinical trials
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of ALK-driven malignancies
Luca Mologni & Carlo Gambacorti-Passerini
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
Relevant Topics in Clinical